Cellyan Biotechnology announces 1-for-20 reverse stock split effective Oct. 26
HKPD•Cellyan Biotechnology expects a 1-for-20 reverse stock split of its Class A and Class B ordinary shares to take effect Oct. 26, 2026, to regain compliance with Nasdaq’s minimum bid price requirement.
1. Split details
Cellyan Biotechnology expects the reverse split to take effect Oct. 26, 2026. Split-adjusted trading in its Class A ordinary shares will begin on Nasdaq at the market open that day under ticker HKPD. The company said the consolidation aims to regain compliance with the Nasdaq Capital Market’s minimum bid price requirement for continued listing.
